Profile	GDS4460 / 241879_at
Title	Pimecrolimus and betamethasone valerate effects on lesional skin of actopic dermatitis
Organism	Homo sapiens

Graph caption help

Sample	Title	Value	Rank
GSM803586	patient 6, baseline	1170.4	96
GSM803589	patient 7, baseline	267.8	83
GSM803592	patient 8, baseline	660.6	93
GSM803595	patient 10, baseline	677.2	93
GSM803598	patient 11, baseline	354.6	86
GSM803601	patient 12, baseline	776.9	94
GSM803604	patient 13, baseline	1280.4	96
GSM803607	patient 14, baseline	316.5	85
GSM803610	patient 15, baseline	1054	95
GSM803613	patient 16, baseline	204.6	79
GSM803587	patient 6, arm treated with pimecrolimus	200	79
GSM803590	patient 7, arm treated with pimecrolimus	368.8	87
GSM803593	patient 8, arm treated with pimecrolimus	136.8	73
GSM803605	patient 13, arm treated with pimecrolimus	354.1	86
GSM803608	patient 14, arm treated with pimecrolimus	504.6	90
GSM803599	patient 11, arm treated with pimecrolimus	904.3	95
GSM803611	patient 15, arm treated with pimecrolimus	259.1	82
GSM803614	patient 16, arm treated with pimecrolimus	432.8	89
GSM803602	patient 12, arm treated with pimecrolimus	388.8	87
GSM803596	patient 10, arm treated with pimecrolimus	475	90
GSM803591	patient 8, arm treated with betamethasone	458.8	89
GSM803609	patient 15, arm treated with betamethasone	649.1	93
GSM803597	patient 11, arm treated with betamethasone	482.6	90
GSM803585	patient 6, arm treated with betamethasone	248.8	82
GSM803603	patient 13, arm treated with betamethasone	897.2	95
GSM803612	patient 16, arm treated with betamethasone	297.1	84
GSM803588	patient 7, arm treated with betamethasone	382.5	87
GSM803594	patient 10, arm treated with betamethasone	236.6	81
GSM803600	patient 12, arm treated with betamethasone	953	95
GSM803606	patient 14, arm treated with betamethasone	362.7	86